Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Qingqing Meng is active.

Publication


Featured researches published by Qingqing Meng.


ChemMedChem | 2014

Design, Synthesis, and Biological Evaluation of Shikonin and Alkannin Derivatives as Potential Anticancer Agents via a Prodrug Approach

Rubing Wang; Wen Zhou; Qingqing Meng; Xu Zhang; Jing Ding; Yan Xu; Hualong Song; Kai Yang; Jiahua Cui; Shaoshun Li

To minimize the cytotoxicity of shikonin and alkannin that arises through the generation of reactive oxygen species (ROS) and alkylation of the naphthazarin ring, two series of novel core‐scaffold‐modified shikonin and alkannin derivatives were designed. These derivatives, which differ in their configurational and positional isomerism (R‐, S‐, and 2‐ and 6‐isomers) were synthesized in high enantiomeric excess (>99 % ee). The selectivity of the dimethylated derivatives was significantly higher than the parent shikonin in vitro, but some side effects were still observed in vivo. Surprisingly, the dimethylated diacetyl derivatives with poor anticancer activity in vitro showed tumor‐inhibiting effects similar to paclitaxel without any toxicity in vivo. The anticancer activity of these derivatives is in agreement with their low ROS generation and alkylating capacity, emphasizing their potential as prodrugs. This strategy provides means to address the nonspecific cytotoxicity of naphthazarin analogues toward normal cells.


Aaps Pharmscitech | 2015

Antitumor Activity of DMAKO-05, a Novel Shikonin Derivative, and Its Metabolism in Rat Liver Microsome

Xu Zhang; Rubing Wang; Wen Zhou; Sui Xiao; Qingqing Meng; Shaoshun Li

The antitumor activity of shikonin derivatives is largely dependent on the generation of superoxide radicals and the alkylation activity of their naphthoquinone moiety. However, our recent study showed that 1,4-dioxime-5,8-dimethoxynaphthalene (DMAKO-05), a novel shikonin derivative, displayed more potential antitumor activity and less toxicity compared to fluorouracil (5-FU) both in vitro and in vivo, even though the hydroxyl and carbonyl groups of its naphthoquinone structure were shielded. To understand the underlying mechanisms, we investigated the metabolism of DMAKO-05 in rat liver microsomes. The kinetic analysis indicated that DMAKO-05 underwent a biphasic metabolism in rat liver microsomes. The inhibition experiments showed that CYP1A and CYP3A were the major enzymes in the metabolism of DMAKO-05, along with partial contribution from CYP2A. In addition, the structures of eight DMAKO-05 metabolites, which were characterized by accurate mass and MS/MS fragmentograms, implied that DMAKO-05 was mainly metabolized through the oxygenation of its naphthoquinone nucleus and the hydrolysis of its side chain, instead of the oxidation of hydroxyimine to ketone. Therefore, DMAKO-05 should not be considered as a traditional naphthoquinone prodrug.


Mini-reviews in Medicinal Chemistry | 2018

Advance in Anti-tumor Mechanisms of Shikonin, Alkannin and their Derivatives

Xu Zhang; Jiahua Cui; Qingqing Meng; Shaoshun Li; Wen Zhou; Sui Xiao

Shikonin, alkannin and their derivatives, the main ingredient of Lithospermum erythrorhizon and Arnebia euchroma (Royle) Johnst native to Inner Mongolian and Northwest of China respectively, hold promising potentials for antitumor effects via multiple-target mechanisms. This review will emphasize the importance of their antitumor activity in apoptosis, necroptosis and immunogenic cell death, and expound the relationship of their antitumor activity and naphthoquinone scaffold that could generate ROS and alkylating agent. Meanwhile, the antitumor mechanisms of naturally-occurring shikonin, alkannin and their derivatives, which were divided into the direct interaction involved in alkylating agent, covalently binding the DNA and protein, as well as the indirect interaction mediated by ROS, nonspecifically influencing the mitochondria or multiple signal pathways, will be systematically summarized and discussed.


RSC Advances | 2018

Development of 2-arylbenzo[h]quinolone analogs as selective CYP1B1 inhibitors

Jinyun Dong; Zengtao Wang; Qingqing Meng; Qijing Zhang; Guang Huang; Jiahua Cui; Shaoshun Li

The CYP1B1 enzyme is regarded as a potential target for cancer prevention and therapy. Based on the structure of α-naphthoflavone (ANF), diverse 2-arylbenzo[h]quinolone derivatives were designed, synthesized and evaluated as selective CYP1B1 inhibitors. Compared with ANF, although few of the title compounds possessed comparable or slightly higher CYP1B1 inhibitory activity, these compounds displayed a significantly increased selectivity toward CYP1B1 over CYP1A2. Among them compounds 5e, 5g and 5h potently inhibited the activity of CYP1B1 with IC50 values of 3.6, 3.9 and 4.1 nM respectively, paralleled by an excellent selectivity profile. On the basis of predicted clog P values, these target compounds may exhibit improved water-solubility compared to ANF. In particular, 5h showed a great superiority in the reversal of CYP1B1-mediated docetaxel resistance in vitro. The current study may serve as a good starting point for the further development of more potent as well as specific CYP1B1 inhibitors capable of reversing CYP1B1-mediated anticancer-drug resistance.


Russian Journal of General Chemistry | 2017

An efficient reduction of nitro and bromine naphthalene derivatives

Jinyun Dong; Qijing Zhang; Guang Huang; Qingqing Meng; Shaoshun Li

Reduction of 1,5-dimethoxy-4-nitronaphthalene by hydrazine hydrate was optimized in the course of current study. Influence of metals, temperature and solvents upon the process was tested. Yield of the reaction was the highest in the presence of Zn powder in DMF. Moderate heating made the process slightly more efficient than that at room temperature, whereas high temperature led to a decreased yield. The current approach made it possible to exclude high pressure and diminish experimental costs.


Mini-reviews in Medicinal Chemistry | 2018

Chemistry and Pharmacology of Thioflavones

Jinyun Dong; Qijing Zhang; Qingqing Meng; Zengtao Wang; Shaoshun Li; Jiahua Cui

Thioflavone derivatives are the thio analogs of the core constituent of the natural product class of flavones. Based on the position and oxidation level of sulfur, they can be divided into three major categories: 4-thioflavones, 1-thioflavones and 1-thioflavones 1,1-dioxide. In recent years, great efforts have been made to develop an approach for the synthesis of thioflavones, especially 1- thioflavones with high functional group compatibility, high yields, low toxicity as well as proceeding under a mild condition, and a variety of synthetic protocols have been developed, the method of choice being dependent on the nature of substrates. As isosteric analogs of biologically active flavones, thioflavones also exhibit various pharmaceutical properties, such as antimicrobial, anticancer and neuroprotective activities. Replacement of the oxygen atom on flavone skeleton by a sulfur atom resulted in modified biological effects due in most part to the change of the structural properties. However, these varying effects depend on the substituents present and the test species. To provide a comprehensive vision of this class of compounds, this review primarily focuses on the structure, synthetic methods, biological properties as well as structure-activity relationships of thioflavones.


Chemical & Pharmaceutical Bulletin | 2018

Cytotoxicity of Synthesized 1,4-Naphthoquinone Oxime Derivatives on Selected Human Cancer Cell Lines

Qijing Zhang; Jinyun Dong; Jiahua Cui; Guang Huang; Qingqing Meng; Shaoshun Li

In an effort to develop potent and selective antitumor agents, a series of 1,4-naphthoquinone oxime derivatives were designed and synthesized. The cytotoxicity of these compounds were evaluated against five human cancer cell lines (colorectal cancer cell: HCT-15, breast cancer cell: MDA-MB-231, liver cancer cell: BEL-7402, colorectal cancer cell: HCT-116 and ovarian cancer cell: A2780) in vitro. Among them, compound 14 was found to be the most potent cytotoxic compound against three cell lines (MDA-MB-231, BEL-7402 and A2780) with IC50 values of 0.66±0.05, 5.11±0.12 and 8.26±0.22 µM, respectively. Additionally, the length of the side chains and the position of the substituent may also affect the cytotoxic activity of the naphthoquinone oxime derivatives. In general, compound 14 effectively inhibited breast cancer cell proliferation and may become a promising anticancer agent.


Russian Journal of General Chemistry | 2017

An Efficient Synthesis of (R or S)-4-Methyl-1-(1,4,5,8-tetramethoxynaphthalen-2-yl)pent-3-ene-1-thiol

Guang Huang; Hui-ran Zhao; Wen Zhou; Qingqing Meng; Qijing Zhang; Jinyun Dong; Bao-quan Zhu; Shaoshun Li

Based on thilation by the Lawesson’s reagent (LR), a concise and efficient synthesis of (R or S)-4-methyl-1-(1,4,5,8-tetramethoxynaphthalen-2-yl)pent-3-ene-1-thiol was developed with relatively high yield.


Russian Journal of General Chemistry | 2016

A simplified synthesis of 2-acetyl-1,4,5,8-tetramethoxynaphthalene and its selective demethylation product

Jinyun Dong; Qijing Zhang; Qingqing Meng; Guang Huang; Wen Zhou; Shaoshun Li

Based on the Friedel–Crafts acylation reaction, a one-step synthesis of 2-acetyl-1,4,5,8-tetramethoxynaphthalene and its selective demethylation product was carried out under various reaction conditions. The product and yield of the reaction were highly catalyst and solvent dependent. The developed method is characterized by short process time, low cost, mild conditions, simple work-out, high yield, and low chemical waste.


Journal of Medicinal Chemistry | 2015

Design and Synthesis of New α-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression.

Jiahua Cui; Qingqing Meng; Xu Zhang; Qing Cui; Wen Zhou; Shaoshun Li

Collaboration


Dive into the Qingqing Meng's collaboration.

Top Co-Authors

Avatar

Shaoshun Li

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Jinyun Dong

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Qijing Zhang

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Guang Huang

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Jiahua Cui

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Wen Zhou

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Xu Zhang

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Zengtao Wang

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Rubing Wang

Shanghai Jiao Tong University

View shared research outputs
Researchain Logo
Decentralizing Knowledge